Arterys, a software-as-a-service (SAAS) analytics platform developer, has secured the US Food and Drug Administration (FDA) 510(k) clearance for its Arterys Software.

The clearance will enable usage of the product in clinical settings for the quantification of cardiac flow in the form of 4D flow and 2D Phase Contrast workflows, and cardiac function measurements.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The software easily integrates into clinical practice to facilitate a comprehensive, easy and fast Cardiac MR imaging.

"We believe that our 4D Flow software represents a significant advance in medical imaging, making scans more accessible, useful, and practical for patients and medical professionals."

Arterys CEO Fabien Beckers said: "We are thrilled to gain FDA clearance for visualization and quantification of cardiovascular MR images.

"The entire Arterys team is committed to providing technology that is valuable to clinicians and also improves their workflow.

See Also:

"We believe that our 4D Flow software represents a significant advance in medical imaging, making scans more accessible, useful, and practical for patients and medical professionals."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The product uses multi-slice, multi-phase and velocity encoded MR images in 4D to specifically analyse the blood flow to the heart.

It provides clinically-relevant and reproducible, quantitative data which has been tested and validated on MR images acquired from both 1.5T and 3.0T MR Scanners.

The data provided by the Arterys Software will support cardiologists, radiologists, and other licensed healthcare practitioners to make clinical decisions.

The Arterys Software will primarily be used for complex congenital heart disease, shunts and collateral vessels, aortic disease and valvular disease.

Arterys is planning to launch the software as ViosWorks 4D product in the US partnering with GE Healthcare.